These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 8027488
1. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release. Touqui L, Herpin-Richard N, Gene RM, Jullian E, Aljabi D, Hamberger C, Vargaftig BB, Dessange JF. J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488 [Abstract] [Full Text] [Related]
3. Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein. Tedeschi A, Milazzo N, Miadonna A. Eur Respir J; 1994 Aug; 7(8):1445-51. PubMed ID: 7525344 [Abstract] [Full Text] [Related]
4. Identification of platelet-activating factor acetylhydrolase II in human skin. Marques M, Pei Y, Southall MD, Johnston JM, Arai H, Aoki J, Inoue T, Seltmann H, Zouboulis CC, Travers JB. J Invest Dermatol; 2002 Oct; 119(4):913-9. PubMed ID: 12406338 [Abstract] [Full Text] [Related]
5. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation. Svetlov SI, Howard KM, Miwa M, Flickinger BD, Olson MS. Arch Biochem Biophys; 1996 Mar 01; 327(1):113-22. PubMed ID: 8615681 [Abstract] [Full Text] [Related]
6. Nasal neutrophilia and release of myeloperoxidase induced by nasal challenge with platelet activating factor: different degrees of responsiveness in atopic and nonatopic subjects. Miadonna A, Milazzo N, Lorini M, Sala A, Tedeschi A. J Allergy Clin Immunol; 1996 Apr 01; 97(4):947-54. PubMed ID: 8655890 [Abstract] [Full Text] [Related]
7. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Tselepis AD, John Chapman M. Atheroscler Suppl; 2002 Dec 01; 3(4):57-68. PubMed ID: 12573364 [Abstract] [Full Text] [Related]
8. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. Triggiani M, De Marino V, Sofia M, Faraone S, Ambrosio G, Carratù L, Marone G. Am J Respir Crit Care Med; 1997 Jul 01; 156(1):94-100. PubMed ID: 9230731 [Abstract] [Full Text] [Related]
9. Extra- and intracellular metabolism of platelet-activating factor by cultured mesangial cells. Neuwirth R, Ardaillou N, Schlondorff D. Am J Physiol; 1989 Apr 01; 256(4 Pt 2):F735-41. PubMed ID: 2705543 [Abstract] [Full Text] [Related]
10. Characterization of phospholipase A2 from human nasal lavage. Stadel JM, Hoyle K, Naclerio RM, Roshak A, Chilton FH. Am J Respir Cell Mol Biol; 1994 Jul 01; 11(1):108-13. PubMed ID: 8018333 [Abstract] [Full Text] [Related]
11. Platelet-activating factor and human thyroid cancer. Denizot Y, Chianéa T, Labrousse F, Truffinet V, Delage M, Mathonnet M. Eur J Endocrinol; 2005 Jul 01; 153(1):31-40. PubMed ID: 15994743 [Abstract] [Full Text] [Related]
12. Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2. Satoh K, Imaizumi T, Kawamura Y, Yoshida H, Hiramoto M, Takamatsu S, Takamatsu M. J Clin Invest; 1991 Feb 01; 87(2):476-81. PubMed ID: 1846878 [Abstract] [Full Text] [Related]
13. The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice. Jiang Z, Fehrenbach ML, Ravaioli G, Kokalari B, Redai IG, Sheardown SA, Wilson S, Macphee C, Haczku A. Respir Res; 2012 Nov 12; 13(1):100. PubMed ID: 23140447 [Abstract] [Full Text] [Related]
14. Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases. Yanoshita R, Kudo I, Ikizawa K, Chang HW, Kobayashi S, Ohno M, Nojima S, Inoue K. J Biochem; 1988 May 12; 103(5):815-9. PubMed ID: 3182751 [Abstract] [Full Text] [Related]
15. Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery. Stephens CJ, Graham RM, Yadava OP, Leong LL, Sturm MJ, Taylor RR. Cardiovasc Res; 1992 Jan 12; 26(1):25-31. PubMed ID: 1516109 [Abstract] [Full Text] [Related]
16. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma. Parks JE, Hough SR. J Androl; 1993 Jan 12; 14(5):335-9. PubMed ID: 8288488 [Abstract] [Full Text] [Related]
17. Possible origins of PAF-acether and lyso-PAF-acether in rat lung alveoli secondary to hypoxia. Prévost MC, Cariven C, Chap H. Biochim Biophys Acta; 1988 Oct 14; 962(3):354-61. PubMed ID: 3167085 [Abstract] [Full Text] [Related]
18. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor. Suzuki Y, Miwa M, Harada M, Matsumoto M. Eur J Biochem; 1988 Feb 15; 172(1):117-20. PubMed ID: 3345757 [Abstract] [Full Text] [Related]
19. Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways. Miadonna A, Tedeschi A, Arnoux B, Sala A, Zanussi C, Benveniste J. Am Rev Respir Dis; 1989 Jul 15; 140(1):142-7. PubMed ID: 2546468 [Abstract] [Full Text] [Related]
20. Inhibition of platelet-activating factor (PAF) acetylhydrolase by methyl arachidonyl fluorophosphonate potentiates PAF synthesis in thrombin-stimulated human coronary artery endothelial cells. Kell PJ, Creer MH, Crown KN, Wirsig K, McHowat J. J Pharmacol Exp Ther; 2003 Dec 15; 307(3):1163-70. PubMed ID: 14560038 [Abstract] [Full Text] [Related] Page: [Next] [New Search]